Curexo (A060280) Stock Overview
Engages in the development and sale of medical devices in South Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for A060280 from our risk checks.
A060280 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Curexo Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩13,090.00 |
| 52 Week High | ₩22,550.00 |
| 52 Week Low | ₩7,880.00 |
| Beta | 1.22 |
| 1 Month Change | -22.64% |
| 3 Month Change | -23.72% |
| 1 Year Change | 33.98% |
| 3 Year Change | 28.84% |
| 5 Year Change | 30.90% |
| Change since IPO | 271.88% |
Recent News & Updates
Recent updates
Shareholder Returns
| A060280 | KR Consumer Retailing | KR Market | |
|---|---|---|---|
| 7D | -3.0% | -5.2% | 4.6% |
| 1Y | 34.0% | 22.8% | 186.6% |
Return vs Industry: A060280 exceeded the KR Consumer Retailing industry which returned 22.8% over the past year.
Return vs Market: A060280 underperformed the KR Market which returned 186.6% over the past year.
Price Volatility
| A060280 volatility | |
|---|---|
| A060280 Average Weekly Movement | 11.6% |
| Consumer Retailing Industry Average Movement | 6.3% |
| Market Average Movement | 9.4% |
| 10% most volatile stocks in KR Market | 16.6% |
| 10% least volatile stocks in KR Market | 4.9% |
Stable Share Price: A060280 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A060280's weekly volatility (12%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 105 | Jaejun Lee | www.curexo.com |
Curexo Inc. engages in the development and sale of medical devices in South Korea and internationally. It operates through Medical Robot, Implant, and Trading divisions. The company’s products include artificial joint surgery robots, such as CUVIS-joint, ROBODOC, and TSolution One surgical systems; CUVIS-spine, a navigation-based spine surgery robot; Morning Walk S200, a walking rehabilitation robot system; and InMotion Arm, a robotic rehabilitation device used in upper limb rehabilitation.
Curexo Inc. Fundamentals Summary
| A060280 fundamental statistics | |
|---|---|
| Market cap | ₩540.09b |
| Earnings (TTM) | ₩2.14b |
| Revenue (TTM) | ₩70.92b |
Is A060280 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A060280 income statement (TTM) | |
|---|---|
| Revenue | ₩70.92b |
| Cost of Revenue | ₩47.92b |
| Gross Profit | ₩23.00b |
| Other Expenses | ₩20.86b |
| Earnings | ₩2.14b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 51.79 |
| Gross Margin | 32.43% |
| Net Profit Margin | 3.01% |
| Debt/Equity Ratio | 0% |
How did A060280 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/24 20:34 |
| End of Day Share Price | 2026/05/22 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Curexo Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Song-hyup Han | Daishin Securities Co. Ltd. |
| Kyeongkeun Kang | NH Investment & Securities Co., Ltd. |
| Jin-Hyoeng Park | Yuanta Securities Korea Co., Ltd. |